866-997-4948(US-Canada Toll Free)

Global Bevacizumab Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Published By :

Globalinforesearch

Published Date : Jan 2019

Category :

Pharmaceutical

No. of Pages : 104 Pages

Bevacizumab, sold under the trade name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease.

Scope of the Report:
The global Bevacizumab market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bevacizumab.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Bevacizumab market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bevacizumab market by product type and applications/end industries.

Market Segment by Companies, this report covers
Genentech
Amgen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Avastin (bevacizumab)
Mvasi (bevacizumab-awwb)

Market Segment by Applications, can be divided into
Cancer
Eye Diease
Table of Contents

1 Bevacizumab Market Overview
1.1 Product Overview and Scope of Bevacizumab
1.2 Classification of Bevacizumab by Types
1.2.1 Global Bevacizumab Revenue Comparison by Types (2019-2024)
1.2.2 Global Bevacizumab Revenue Market Share by Types in 2018
1.2.3 Avastin (bevacizumab)
1.2.4 Mvasi (bevacizumab-awwb)
1.3 Global Bevacizumab Market by Application
1.3.1 Global Bevacizumab Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cancer
1.3.3 Eye Diease
1.4 Global Bevacizumab Market by Regions
1.4.1 Global Bevacizumab Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Bevacizumab Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Bevacizumab Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bevacizumab Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Bevacizumab Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bevacizumab Status and Prospect (2014-2024)
1.5 Global Market Size of Bevacizumab (2014-2024)
2 Manufacturers Profiles
2.1 Genentech
2.1.1 Business Overview
2.1.2 Bevacizumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genentech Bevacizumab Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Bevacizumab Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Bevacizumab Revenue, Gross Margin and Market Share (2017-2018)
3 Global Bevacizumab Market Competition, by Players
3.1 Global Bevacizumab Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Bevacizumab Players Market Share
3.2.2 Top 10 Bevacizumab Players Market Share
3.3 Market Competition Trend
4 Global Bevacizumab Market Size by Regions
4.1 Global Bevacizumab Revenue and Market Share by Regions
4.2 North America Bevacizumab Revenue and Growth Rate (2014-2019)
4.3 Europe Bevacizumab Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Bevacizumab Revenue and Growth Rate (2014-2019)
4.5 South America Bevacizumab Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Bevacizumab Revenue and Growth Rate (2014-2019)
5 North America Bevacizumab Revenue by Countries
5.1 North America Bevacizumab Revenue by Countries (2014-2019)
5.2 USA Bevacizumab Revenue and Growth Rate (2014-2019)
5.3 Canada Bevacizumab Revenue and Growth Rate (2014-2019)
5.4 Mexico Bevacizumab Revenue and Growth Rate (2014-2019)
6 Europe Bevacizumab Revenue by Countries
6.1 Europe Bevacizumab Revenue by Countries (2014-2019)
6.2 Germany Bevacizumab Revenue and Growth Rate (2014-2019)
6.3 UK Bevacizumab Revenue and Growth Rate (2014-2019)
6.4 France Bevacizumab Revenue and Growth Rate (2014-2019)
6.5 Russia Bevacizumab Revenue and Growth Rate (2014-2019)
6.6 Italy Bevacizumab Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Bevacizumab Revenue by Countries
7.1 Asia-Pacific Bevacizumab Revenue by Countries (2014-2019)
7.2 China Bevacizumab Revenue and Growth Rate (2014-2019)
7.3 Japan Bevacizumab Revenue and Growth Rate (2014-2019)
7.4 Korea Bevacizumab Revenue and Growth Rate (2014-2019)
7.5 India Bevacizumab Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Bevacizumab Revenue and Growth Rate (2014-2019)
8 South America Bevacizumab Revenue by Countries
8.1 South America Bevacizumab Revenue by Countries (2014-2019)
8.2 Brazil Bevacizumab Revenue and Growth Rate (2014-2019)
8.3 Argentina Bevacizumab Revenue and Growth Rate (2014-2019)
8.4 Colombia Bevacizumab Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Bevacizumab by Countries
9.1 Middle East and Africa Bevacizumab Revenue by Countries (2014-2019)
9.2 Saudi Arabia Bevacizumab Revenue and Growth Rate (2014-2019)
9.3 UAE Bevacizumab Revenue and Growth Rate (2014-2019)
9.4 Egypt Bevacizumab Revenue and Growth Rate (2014-2019)
9.5 Nigeria Bevacizumab Revenue and Growth Rate (2014-2019)
9.6 South Africa Bevacizumab Revenue and Growth Rate (2014-2019)
10 Global Bevacizumab Market Segment by Type
10.1 Global Bevacizumab Revenue and Market Share by Type (2014-2019)
10.2 Global Bevacizumab Market Forecast by Type (2019-2024)
10.3 Avastin (bevacizumab) Revenue Growth Rate (2014-2024)
10.4 Mvasi (bevacizumab-awwb) Revenue Growth Rate (2014-2024)
11 Global Bevacizumab Market Segment by Application
11.1 Global Bevacizumab Revenue Market Share by Application (2014-2019)
11.2 Bevacizumab Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2014-2019)
11.4 Eye Diease Revenue Growth (2014-2019)
12 Global Bevacizumab Market Size Forecast (2019-2024)
12.1 Global Bevacizumab Market Size Forecast (2019-2024)
12.2 Global Bevacizumab Market Forecast by Regions (2019-2024)
12.3 North America Bevacizumab Revenue Market Forecast (2019-2024)
12.4 Europe Bevacizumab Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Bevacizumab Revenue Market Forecast (2019-2024)
12.6 South America Bevacizumab Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Bevacizumab Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Table

List of Tables and Figures

Figure Bevacizumab Picture
Table Product Specifications of Bevacizumab
Table Global Bevacizumab and Revenue (Million USD) Market Split by Product Type
Figure Global Bevacizumab Revenue Market Share by Types in 2018
Figure Avastin (bevacizumab) Picture
Figure Mvasi (bevacizumab-awwb) Picture
Table Global Bevacizumab Revenue (Million USD) by Application (2014-2024)
Figure Bevacizumab Revenue Market Share by Applications in 2018
Figure Cancer Picture
Figure Eye Diease Picture
Table Global Market Bevacizumab Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Bevacizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Bevacizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Bevacizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Bevacizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Bevacizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Bevacizumab Revenue (Million USD) and Growth Rate (2014-2024)
Table Genentech Basic Information, Manufacturing Base and Competitors
Table Genentech Bevacizumab Type and Applications
Table Genentech Bevacizumab Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Bevacizumab Type and Applications
Table Amgen Bevacizumab Revenue, Gross Margin and Market Share (2017-2018)
Table Global Bevacizumab Revenue (Million USD) by Players (2014-2019)
Table Global Bevacizumab Revenue Share by Players (2014-2019)
Figure Global Bevacizumab Revenue Share by Players in 2017
Figure Global Bevacizumab Revenue Share by Players in 2018
Figure Global Top 5 Players Bevacizumab Revenue Market Share in 2018
Figure Global Top 10 Players Bevacizumab Revenue Market Share in 2018
Figure Global Bevacizumab Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Bevacizumab Revenue (Million USD) by Regions (2014-2019)
Table Global Bevacizumab Revenue Market Share by Regions (2014-2019)
Figure Global Bevacizumab Revenue Market Share by Regions (2014-2019)
Figure Global Bevacizumab Revenue Market Share by Regions in 2018
Figure North America Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Europe Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Bevacizumab Revenue and Growth Rate (2014-2019)
Figure South America Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Bevacizumab Revenue and Growth Rate (2014-2019)
Table North America Bevacizumab Revenue by Countries (2014-2019)
Table North America Bevacizumab Revenue Market Share by Countries (2014-2019)
Figure North America Bevacizumab Revenue Market Share by Countries (2014-2019)
Figure North America Bevacizumab Revenue Market Share by Countries in 2018
Figure USA Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Canada Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Mexico Bevacizumab Revenue and Growth Rate (2014-2019)
Table Europe Bevacizumab Revenue (Million USD) by Countries (2014-2019)
Figure Europe Bevacizumab Revenue Market Share by Countries (2014-2019)
Figure Europe Bevacizumab Revenue Market Share by Countries in 2018
Figure Germany Bevacizumab Revenue and Growth Rate (2014-2019)
Figure UK Bevacizumab Revenue and Growth Rate (2014-2019)
Figure France Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Russia Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Italy Bevacizumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Bevacizumab Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Bevacizumab Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Bevacizumab Revenue Market Share by Countries in 2018
Figure China Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Japan Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Korea Bevacizumab Revenue and Growth Rate (2014-2019)
Figure India Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Bevacizumab Revenue and Growth Rate (2014-2019)
Table South America Bevacizumab Revenue by Countries (2014-2019)
Table South America Bevacizumab Revenue Market Share by Countries (2014-2019)
Figure South America Bevacizumab Revenue Market Share by Countries (2014-2019)
Figure South America Bevacizumab Revenue Market Share by Countries in 2018
Figure Brazil Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Argentina Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Colombia Bevacizumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Bevacizumab Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Bevacizumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Bevacizumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Bevacizumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Bevacizumab Revenue and Growth Rate (2014-2019)
Figure UAE Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Egypt Bevacizumab Revenue and Growth Rate (2014-2019)
Figure Nigeria Bevacizumab Revenue and Growth Rate (2014-2019)
Figure South Africa Bevacizumab Revenue and Growth Rate (2014-2019)
Table Global Bevacizumab Revenue (Million USD) by Type (2014-2019)
Table Global Bevacizumab Revenue Share by Type (2014-2019)
Figure Global Bevacizumab Revenue Share by Type (2014-2019)
Figure Global Bevacizumab Revenue Share by Type in 2019
Table Global Bevacizumab Revenue Forecast by Type (2019-2024)
Figure Global Bevacizumab Market Share Forecast by Type (2019-2024)
Figure Global Avastin (bevacizumab) Revenue Growth Rate (2014-2019)
Figure Global Mvasi (bevacizumab-awwb) Revenue Growth Rate (2014-2019)
Table Global Bevacizumab Revenue by Application (2014-2019)
Table Global Bevacizumab Revenue Share by Application (2014-2019)
Figure Global Bevacizumab Revenue Share by Application (2014-2019)
Figure Global Bevacizumab Revenue Share by Application in 2019
Table Global Bevacizumab Revenue Forecast by Application (2019-2024)
Figure Global Bevacizumab Market Share Forecast by Application (2019-2024)
Figure Global Cancer Revenue Growth Rate (2014-2019)
Figure Global Eye Diease Revenue Growth Rate (2014-2019)
Figure Global Bevacizumab Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Bevacizumab Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Bevacizumab Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Bevacizumab Revenue Market Forecast (2019-2024)
Figure Europe Bevacizumab Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Bevacizumab Revenue Market Forecast (2019-2024)
Figure South America Bevacizumab Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Bevacizumab Revenue Market Forecast (2019-2024)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *